ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,263.20
      -1.69%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      79.285
      0.00%
      Bitcoin
      93,750.40
      -0.87%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Climb Bio Inc (CLYM) Quote

      Climb Bio Inc

      Climb Bio Inc (CLYM)

      NASDAQ
      2.00
      0.13
      (6.95%)
      Closed January 12 4:00PM
      Delayed by 15 minutes
      2.00
      -0.01
      (-0.50%)
      After Hours: 7:35PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      2.00
      Bid
      1.88
      Ask
      2.75
      Volume
      1,687,968
      1.97 Day's Range 2.2669
      1.73 52 Week Range 5.86
      Market Cap
      134.448M
      Previous Close
      1.87
      Open
      2.08
      Last Trade
      100
      @
      2
      (formt)
      Last Trade Time
      Financial Volume
      $ 3,394,919
      VWAP
      2.0112
      Average Volume (3m)
      331,015
      Shares Outstanding
      67,223,760
      Dividend Yield
      -
      PE Ratio
      -9.78
      Earnings Per Share (EPS)
      -0.52
      Revenue
      -
      Net Profit
      -35.12M

      About Climb Bio Inc

      Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cel... Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Companys lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      climbbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Climb Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLYM. The last closing price for Climb Bio was $1.87. Over the last year, Climb Bio shares have traded in a share price range of $ 1.73 to $ 5.86.

      Climb Bio currently has 67,223,760 shares outstanding. The market capitalization of Climb Bio is $125.71 million. Climb Bio has a price to earnings ratio (PE ratio) of -9.78.

      Ask ADVFN Intelligence (AI)

      CLYM Latest News

      More News

      Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

      Transaction Expands Climb Bio’s Pipeline of B-cell Targeted Therapeutics to Address Immune-mediated Diseases New Program is a Highly Potent, Fc-engineered anti-APRIL Monoclonal Antibody...

      January 09 2025
      GlobeNewswire Inc.

      Climb Bio to be Added to the Nasdaq Biotechnology Index

      WELLESLEY HILLS, Mass., Dec. 19, 2024 (GLOBE NEWSWIRE) -- December 19, 2024 – Climb Bio, Inc. (Nasdaq: CLYM) today announced that the company will be added to the NASDAQ Biotech Index (Nasdaq:...

      December 19 2024
      GlobeNewswire Inc.

      Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

      Appointed Douglas Williams, Ph.D. as Chair of the Board of Directors FDA Clearance of Investigational New Drug Application (IND) for systemic lupus erythematosus (SLE) Expanded Management Team...

      November 12 2024
      GlobeNewswire Inc.

      Climb Bio Appoints Douglas E. Williams, Ph.D., as Chair of the Board

      WELLESLEY, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM) today announced the appointment of Douglas E. Williams, Ph.D., as Climb Bio’s Chair of its Board of Directors...

      November 11 2024
      GlobeNewswire Inc.

      Climb Bio to Present at Upcoming Investor Conferences

      WELLESLEY, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that members of its executive team are scheduled to participate in the upcoming investor conferences...

      October 31 2024
      GlobeNewswire Inc.

      Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

      Completes Transition to Immune-Mediated Disease Focused Company Highlights Additional Data from Phase 1b Primary Membranous Nephropathy (pMN) Study with plans to Advance to Late Phase Development...

      October 15 2024
      GlobeNewswire Inc.

      Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

      WELLESLEY, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that it will present data at the American Society of Nephrology Kidney Week 2024, which will take...

      October 11 2024
      GlobeNewswire Inc.

      Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

      WELLESLEY, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will present and host investor meetings at William Blair’s Transforming Autoimmune Diseases...

      October 04 2024
      GlobeNewswire Inc.

      Climb Bio to Host Virtual Investor Event on October 15, 2024

      WELLESLEY, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will host a virtual investor day on October 15, 2024. The event will feature members of...

      October 03 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.09-4.306220095692.092.361.872419172.18782505CS
      4-0.9-31.03448275862.92.91.734560182.0596687CS
      12-2.87-58.9322381934.875.11.733310152.963888CS
      26-3.03-60.23856858855.035.861.733371043.35500845CS
      52-3.03-60.23856858855.035.861.733371043.35500845CS
      156-3.03-60.23856858855.035.861.733371043.35500845CS
      260-3.03-60.23856858855.035.861.733371043.35500845CS

      CLYM - Frequently Asked Questions (FAQ)

      What is the current Climb Bio share price?
      The current share price of Climb Bio is $ 2.00
      How many Climb Bio shares are in issue?
      Climb Bio has 67,223,760 shares in issue
      What is the market cap of Climb Bio?
      The market capitalisation of Climb Bio is USD 125.71M
      What is the 1 year trading range for Climb Bio share price?
      Climb Bio has traded in the range of $ 1.73 to $ 5.86 during the past year
      What is the PE ratio of Climb Bio?
      The price to earnings ratio of Climb Bio is -9.78
      What is the reporting currency for Climb Bio?
      Climb Bio reports financial results in USD
      What is the latest annual profit for Climb Bio?
      The latest annual profit of Climb Bio is USD -35.12M
      What is the registered address of Climb Bio?
      The registered address for Climb Bio is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
      What is the Climb Bio website address?
      The website address for Climb Bio is climbbio.com
      Which industry sector does Climb Bio operate in?
      Climb Bio operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VRMEVerifyMe Inc
      $ 2.57
      (52.98%)
      		57.83M
      WKEYWISeKey International Holdings AG
      $ 10.041
      (52.83%)
      		6.72M
      DATSDatChat Inc
      $ 4.8105
      (49.86%)
      		158.65M
      CDTConduit Pharmaceuticals Inc
      $ 0.1214
      (48.05%)
      		1.17B
      INTZIntrusion Inc
      $ 2.8888
      (44.44%)
      		40.61M
      IGMSIGM Biosciences Inc
      $ 2.095
      (-66.21%)
      		5.69M
      CDTGCDT Environmental Technology Investment Holdings Ltd
      $ 1.87
      (-51.30%)
      		2.28M
      MODVModivCare Inc
      $ 6.51
      (-47.88%)
      		2.73M
      AIFUAIX Inc
      $ 0.420501
      (-47.76%)
      		7.83M
      MRSNMersana Therapeutics Inc
      $ 0.691
      (-46.85%)
      		58.31M
      CDTConduit Pharmaceuticals Inc
      $ 0.1214
      (48.05%)
      		1.16B
      NVDANVIDIA Corporation
      $ 135.91
      (-3.00%)
      		203.27M
      RGTIRigetti Computing Inc
      $ 8.9299
      (-11.06%)
      		175.21M
      VMARVision Marine Technologies Inc
      $ 2.14
      (40.79%)
      		174.99M
      DATSDatChat Inc
      $ 4.8105
      (49.86%)
      		158.56M

      Discussion

      View Full Feed
      fuagf fuagf 15 minutes ago
      hap0206, Corruption, yeah,

      "and you should ask yourself -- who are the stupid ones
      those who believe the veracity off those writings
      or the voters who recognize obvious evil corruption of our political system
      the whole world knows corruption when they see it"
      Alexulf Alexulf 16 minutes ago
      5-Day Change +52.00% A nice floor is building up for the next run. Now, will it be next week already? It is hard to say that the Investor Conference on the 15th will probably impact the share price. Yet, will the big money be invested (or traded) before or after the 15th? Time will tell, only three
      AITX
      KeyKey KeyKey 36 minutes ago
      @lodas: There is nothing really new in your postings, right ?
      Your are repeating same stuff again and again.
      Some users here think that there are still some tasks to be closed before further can proceed. So the only thing we can do is to wait further and dream about increasing share pr
      COOP
      Mojocash Mojocash 48 minutes ago
      Find your safe place, kid! Scream at the sky! You are a L O S E R !!! Cry Harder!!!!
      Mojocash Mojocash 50 minutes ago
      No clue what you are saying nutjob! You Lost! That is all that matters! Reap it! Loser!
      MagnetLover MagnetLover 55 minutes ago
      I wonder if the settlement has anything to do with the sudden dip in QREE's price.
      Given the precarious position of their cash balance and balance sheet, such a settlement could have easily rendered them insolvent.
      QREE
      Seminole Red Seminole Red 1 hour ago
      I didnt say Ruled, I said some are Leaders and some are Followers, Its been that way through History
      elks elks 1 hour ago
      Wow unbelievable. Might add another big lot now.
      HMBL
      eagle8 eagle8 1 hour ago
      Welcome back ilovetech !

      GLTU
      NWBO
      blackhawks blackhawks 1 hour ago
      You see the links under all of those 'you said'? Those are corroborations of Trump's corruption and stupidity which we saw enough of over the past 8 years. Watch, within the first 90 days a majority of the country will grow to loathe your wannabe dictator.
      4u2nv2 4u2nv2 1 hour ago
      It was just an idea on IFUS raising cattle themselves. I was joking about IFUS giving the ranchers the middle finger and I know they are not going to shift business models. Applying SGP+(AG)™ as a mulch, fertilizer. Just assuming it will increase the profit margins of growing flowers down in Colombi
      IFUS
      HeavenBound83 HeavenBound83 1 hour ago
      Wow! That's quite telling in deed. Good luck to all smart money :-)
      HMBL
      Bob Mullet Bob Mullet 2 hours ago
      Great post pal. 
      KBLB
      New money98 New money98 2 hours ago
      Lmao 🤣 🤣 🤣 🤣.....I know your names doughnut but I'll just call you nut...I know real mck is in jail but geez! The recent posters are making me feel real good about Bioaq.
      weedtrader420 weedtrader420 2 hours ago
      In the next couple days, XRP should be at $2.80 Hopefully today
      XRPUSD
      facts_matter14 facts_matter14 2 hours ago
      Another victory about to happen???


      https://investorshub.advfn.com/uimage/uploads/2025/1/12/ytgfqIMG_6136.gif








      .
      SRMX
      facts_matter14 facts_matter14 2 hours ago
      Another victory about to happen???


      https://investorshub.advfn.com/uimage/uploads/2025/1/12/jhertIMG_6135.gif









      .
      SRMX
      facts_matter14 facts_matter14 2 hours ago
      Another victory about to happen??


      https://investorshub.advfn.com/uimage/uploads/2025/1/12/r[xylIMG_6127.gif










      .
      SRMX
      gitreal gitreal 2 hours ago
      A dozen new aliases showed up on ST suddenly. A bunch of stuff about shorty, MOASS's and other nonsense. I have a feeling a bunch of AABB shares are about to show up.......and a raise in the AS to 5 billion.
      AABB
      microchips microchips 2 hours ago
      The BOD did what needed to be done for shareholders and their own interests. Lebby is a brilliant scientist but he forgot that the primary purpose of the company is to make deals that make money for the company. He was stuck on making the LWLG polymer ubiquitous. That sounds good, but obviously the
      LWLG
      mentholman mentholman 2 hours ago
      😂, they might be but I personally think they have the better looking body style and the interior design is better than most other manufacturers.
      XRPUSD
      weedtrader420 weedtrader420 2 hours ago
      Ram trucks are rust buckets😂🤣
      XRPUSD
      aBeezlee aBeezlee 2 hours ago
      Wow, thank you!
      SMCE

      Your Recent History

      NASDAQ
      CLYM
      Climb Bio
      TG
      NM5
      Nickel Industries
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads